Brodsky & Smith LLC has announced investigations into whether the boards of Veris Residential, XOMA Royalty Corporation, Organon & Co., and RE/MAX Holdings breached their fiduciary duties in recent merger agreements. The investigations focus on whether these companies conducted fair processes and offered fair value to shareholders in their respective acquisitions. The deals involve cash and stock transactions with companies like Affinius Capital, Ligand Pharmaceuticals, Sun Pharmaceutical, and The Real Brokerage. Shareholders concerned about these mergers can contact Brodsky & Smith for more information and possible legal action.
UBS Group AG has notified Bang & Olufsen A/S that its shareholding and voting rights have dropped below the 5% threshold, holding 4.85% as of July 8, 2026. This update is in accordance with the Danish Capital Markets Act, which requires disclosure wh...
Assassin’s Creed Black Flag Resynced, a remake of the 2013 original, sold 2 million copies on its first day, marking a strong launch for Ubisoft. The game achieved the highest concurrent player count ever for the franchise on Steam and topped Twitch ...
VKNG Digital, founded by marketing expert Dave Anderson, has launched to provide high-quality SEO and PPC strategies to small and medium-sized businesses in Lancashire. The agency aims to bridge the gap where smaller businesses often lack access to e...
Q32 Bio will report topline 36-week results from Part B of its Phase 2a SIGNAL-AA clinical trial for bempikibart, a drug targeting severe alopecia areata, on July 13, 2026. The company will hold a conference call and webcast to discuss the data, whic...
VERAXA Biotech AG has appointed Carl von Halem as its interim Chief Financial Officer, succeeding Torsten Bürgermeister. Von Halem has been instrumental in taking VERAXA public and brings extensive experience in finance and life sciences. The company...
